Prices delayed by at least 15 minutes | Print


Puretech Health PLC (PRTC)

ORD 1P
Sell: 223.5p|Buy: 226p|Change: 0 (0%)

Open 

226p


Previous close 

225p


Trade high 

227p


Volume 

29,685


Year high 

242.93p


Year low 

139.00p


Dividend yield 

-


Market capitalisation 

£607.39 mn


P/E ratio 

227.27


ISIN 

GB00BY2Z0H74


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Puretech Health PLC+ 0.90
FTSE 250+ 0.17
More...

Company profile

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202412:41:232259702,182.50
28/03/202412:41:23225357803.25
28/03/202412:41:232251,1702,632.50
28/03/202412:41:23225100225.00
28/03/202412:39:332252,2655,096.25

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.